Clinical Trials Directory

Trials / Suspended

SuspendedNCT06477003

Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

Multispectral Optoacoustic Tomography for the Detection of Extranodal Extension and Radiation Induced Fibrosis in Head and Neck Squamous Cell Cancer

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to assess the safety and evaluate the potential of the Multispectral Optoacoustic Tomography (MSOT) device to more precisely identify and assess the neck lymph nodes which might be affected in patients with metastatic head and neck squamous cell carcinomas.

Detailed description

This is a 2-Arm investigational device study designed to provide safety information regarding the use of the Acuity MSOT device in the clinical setting, and to determine the ability of MSOT imaging data to correlate with clinical findings identified via pathology. Imaging with the MSOT device is expected to obtain information about the number, size, and appearance of the lymph nodes in the neck. The device will be used to obtain images of the tumor or lymph node margins for investigational use only to compare to clinical pathology and patient's medical records. All images will be obtained pre-surgery for Arm 1 patients (undergoing surgery for their cancer) and before, during and after radiotherapy in Arm 2 patients (undergoing radiotherapy treatment for their cancer). The temperature of the patient's skin will also be measured prior to and after each MSOT scan. Once radiotherapy treatment has completed, images using the MSOT device will be obtained every 6 months for 2 years to assess for radiation induced fibrosis. MSOT scans will be for research only and no treatment decisions will be based on the MSOT images obtained.

Conditions

Interventions

TypeNameDescription
DEVICEMultispectral Optoacoustic TomographyThe MSOT device will be used to take images of the tumor or affected lymph nodes of patients with head and neck squamous cell carcinoma.
PROCEDURETemperature MeasurementThe temperature of the skin will be measured prior to and after MSOT imaging.

Timeline

Start date
2026-05-01
Primary completion
2026-11-01
Completion
2027-11-01
First posted
2024-06-27
Last updated
2026-01-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06477003. Inclusion in this directory is not an endorsement.